Adipogen/Enterocin/AG-CN2-0116-C250/250 µg
商品编号：
AG-CN2-0116-C250
品牌：
Adipogen Inc
市场价：
¥800.00
美元价：
480.00
产品分类：
其他试剂
公司分类：
Other_reagents
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
| Product Details | |
|---|---|
| Synonyms | Vulgamycin |
| Product Type | Chemical |
| Properties | |
| Formula | C22H20O10 |
| MW | 444.4 |
| CAS | 59678-46-5 |
| RTECS | PB9245500 |
| Source/Host Chemicals | Isolated from Streptomyces sp. |
| Purity Chemicals | ≥95% (HPLC) |
| Appearance | White solid. |
| Solubility | Soluble in DMSO, ethanol, methanol or water. |
| Declaration | Manufactured by BioLinks K.K. with courtesy strain from The Kitasato Institute. |
| InChi Key | CTBBEXWJRAPJIZ-OTKDDRNCSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Keep cool and dry. |
| Use/Stability | Stable for at least 3 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
- Potent antibiotic.
- Bacteriocin.
- Antibacterial. Broad spectrum activity against Gram-positive and Gram-negative bacteria.
- Herbicidal.
- Enterocin is a small molecular weight secondary metabolite and should not be confused with bacterial proteins isolated from Enterococci generically referred to as "enterocins".
Product References
- Enterocin, a new antibiotic taxonomy, isolation and characterization: N. Miyairi, et al.; J. Antibiot. (Tokyo) 29, 227 (1976)
- Herbicidal activity and mode of action of vulgamycin: P. Babczinski, et al.; Pesticide Sci. 33, 439 (1991)
- Agroactive Compounds of Microbial Origin: Y. Tanaka & S. Omura; Ann. Rev. Microbiol. 47, 57 (1993) (Review)
- Microbial pyran-2-ones and dihydropyran-2-ones: J.M. Dickinson; Nat. Prod. Rep. 10, 71 (1993) (Review)
- Natural Metabolic Diversity Encoded by the Enterocin Biosynthesis Gene Cluster: J. Piel, et al.; JACS 122, 5415 (2000)
- Enzymatic total synthesis of enterocin polyketides: Q. Cheng, et al.; Nat. Chem. Biol. 3, 557 (2007)
品牌介绍
Adipogen公司由三个子公司组成，分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国，运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发，如癌症、免疫、炎症、代谢疾病（糖尿病、肥胖）、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外，也可提供抗体和蛋白产品，Adipogen拥有自己的化学实验室，致力于开发创新型小分子化合物。
联络我们
